SI2252300T1 - Uporaba 2,4-pirimidindiaminov za zdravljenje ateroskleroze - Google Patents
Uporaba 2,4-pirimidindiaminov za zdravljenje aterosklerozeInfo
- Publication number
- SI2252300T1 SI2252300T1 SI200931588A SI200931588A SI2252300T1 SI 2252300 T1 SI2252300 T1 SI 2252300T1 SI 200931588 A SI200931588 A SI 200931588A SI 200931588 A SI200931588 A SI 200931588A SI 2252300 T1 SI2252300 T1 SI 2252300T1
- Authority
- SI
- Slovenia
- Prior art keywords
- pyrimidinediamines
- atherosclerosis
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5383—1,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3090308P | 2008-02-22 | 2008-02-22 | |
PCT/US2009/034718 WO2009105675A1 (en) | 2008-02-22 | 2009-02-20 | Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
EP09711944.0A EP2252300B1 (en) | 2008-02-22 | 2009-02-20 | Use of 2,4-pyrimidinediamines for the treatment of atherosclerosis |
Publications (1)
Publication Number | Publication Date |
---|---|
SI2252300T1 true SI2252300T1 (sl) | 2017-04-26 |
Family
ID=40559977
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200931588A SI2252300T1 (sl) | 2008-02-22 | 2009-02-20 | Uporaba 2,4-pirimidindiaminov za zdravljenje ateroskleroze |
Country Status (21)
Country | Link |
---|---|
US (1) | US8530466B2 (sl) |
EP (1) | EP2252300B1 (sl) |
JP (1) | JP5586482B2 (sl) |
KR (1) | KR101614555B1 (sl) |
CN (1) | CN102014917A (sl) |
AU (1) | AU2009215430B2 (sl) |
BR (1) | BRPI0907724B8 (sl) |
CA (1) | CA2715962C (sl) |
CY (1) | CY1118655T1 (sl) |
DK (1) | DK2252300T3 (sl) |
ES (1) | ES2610880T3 (sl) |
HK (1) | HK1150555A1 (sl) |
HR (1) | HRP20170050T1 (sl) |
HU (1) | HUE030307T2 (sl) |
LT (1) | LT2252300T (sl) |
MX (1) | MX2010009159A (sl) |
PL (1) | PL2252300T3 (sl) |
PT (1) | PT2252300T (sl) |
RU (1) | RU2490015C2 (sl) |
SI (1) | SI2252300T1 (sl) |
WO (1) | WO2009105675A1 (sl) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8338439B2 (en) | 2008-06-27 | 2012-12-25 | Celgene Avilomics Research, Inc. | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
CA2986640C (en) | 2008-06-27 | 2019-03-26 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
US11351168B1 (en) | 2008-06-27 | 2022-06-07 | Celgene Car Llc | 2,4-disubstituted pyrimidines useful as kinase inhibitors |
MX2012007402A (es) | 2009-12-23 | 2012-08-23 | Takeda Pharmaceutical | Pirrolidinonas heteroaromaticas fusionadas como inhibidores de tirosina cinasa esplenica (syk). |
MX2012013274A (es) | 2010-05-21 | 2013-05-28 | Chemilia Ab | Novedosos derivados de la pirimidina. |
KR20130099040A (ko) | 2010-08-10 | 2013-09-05 | 셀진 아빌로믹스 리서치, 인코포레이티드 | Btk 억제제의 베실레이트 염 |
US8975249B2 (en) | 2010-11-01 | 2015-03-10 | Celgene Avilomics Research, Inc. | Heterocyclic compounds and uses thereof |
EP2635285B1 (en) | 2010-11-01 | 2017-05-03 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
US8796255B2 (en) | 2010-11-10 | 2014-08-05 | Celgene Avilomics Research, Inc | Mutant-selective EGFR inhibitors and uses thereof |
US9006241B2 (en) | 2011-03-24 | 2015-04-14 | Noviga Research Ab | Pyrimidine derivatives |
US9056873B2 (en) | 2011-06-22 | 2015-06-16 | Takeda Pharmaceutical Company Limited | Substituted 6-aza-isoindolin-1-one derivatives |
AU2012288632B2 (en) | 2011-07-28 | 2017-08-17 | Rigel Pharmaceuticals, Inc. | New (trimethoxyphenylamino)pyrimidinyl formulations |
CA2853498A1 (en) | 2011-10-28 | 2013-05-02 | Celgene Avilomics Research, Inc. | Methods of treating a bruton's tyrosine kinase disease or disorder |
EP2825041B1 (en) | 2012-03-15 | 2021-04-21 | Celgene CAR LLC | Solid forms of an epidermal growth factor receptor kinase inhibitor |
RS57901B1 (sr) | 2012-03-15 | 2019-01-31 | Celgene Car Llc | Soli inhibitora kinaze receptora epidermalnog faktora rasta |
EP2935226A4 (en) | 2012-12-21 | 2016-11-02 | Celgene Avilomics Res Inc | HETEROARYL COMPOUNDS AND USES THEREOF |
PE20151274A1 (es) | 2013-02-08 | 2015-09-12 | Celgene Avilomics Res Inc | Inhibidores de erk y sus usos |
US9492471B2 (en) | 2013-08-27 | 2016-11-15 | Celgene Avilomics Research, Inc. | Methods of treating a disease or disorder associated with Bruton'S Tyrosine Kinase |
US9415049B2 (en) | 2013-12-20 | 2016-08-16 | Celgene Avilomics Research, Inc. | Heteroaryl compounds and uses thereof |
JP7118642B2 (ja) | 2014-08-08 | 2022-08-16 | アリ リサーチ ソシエタ ア レスポンサビリタ リミタータ センプリフィカタ | 炎症性およびアレルギー性病変の治療に用いるための脂肪酸とパルミトイルエタノールアミドの混合物 |
ES2741785T3 (es) | 2014-08-13 | 2020-02-12 | Celgene Car Llc | Formas y composiciones de un inhibidor de ERK |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2983636B2 (ja) * | 1993-10-01 | 1999-11-29 | ノバルティス アクチェンゲゼルシャフト | 薬理学的に活性なピリジン誘導体及びその製造方法 |
CN1142817A (zh) * | 1993-10-12 | 1997-02-12 | 杜邦麦克制药有限公司 | 1n-烷基-n-芳基嘧啶胺及其衍生物 |
JP2002523497A (ja) * | 1998-08-29 | 2002-07-30 | アストラゼネカ・アクチエボラーグ | ピリミジン化合物 |
GB9828511D0 (en) * | 1998-12-24 | 1999-02-17 | Zeneca Ltd | Chemical compounds |
JP4510442B2 (ja) * | 2001-06-26 | 2010-07-21 | ブリストル−マイヤーズ スクイブ カンパニー | TNF−α発現のN−ヘテロ環インヒビター |
EP1470122B1 (en) | 2002-01-23 | 2007-12-19 | Bayer Pharmaceuticals Corporation | Rho-kinase inhibitors |
EP1483260A1 (de) * | 2002-03-11 | 2004-12-08 | Schering Aktiengesellschaft | Cdk inhibitorische 2-heteroaryl-pyrimidine, deren herstellung und verwendung als arzneimittel |
US7288547B2 (en) | 2002-03-11 | 2007-10-30 | Schering Ag | CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
GB0321710D0 (en) | 2003-09-16 | 2003-10-15 | Novartis Ag | Organic compounds |
TW200517057A (en) * | 2003-09-22 | 2005-06-01 | Basf Ag | Fungicidal mixtures |
AU2005281735A1 (en) * | 2004-09-10 | 2006-03-16 | Nycomed Gmbh | Ciclesonide and syk inhibitor combination and methods of use thereof |
ES2337496T3 (es) * | 2005-01-19 | 2010-04-26 | Rigel Pharmaceuticals, Inc. | Profarmacos de compuestos de 2,4-pirimidindiamina y sus usos. |
DE102005016634A1 (de) * | 2005-04-12 | 2006-10-19 | Merck Patent Gmbh | Neuartige Aza-Hetercyclen als Kinase-Inhibitoren |
WO2007008541A2 (en) | 2005-07-08 | 2007-01-18 | Kalypsys, Inc. | Cellular cholesterol absorption modifiers |
AU2006309013B2 (en) * | 2005-11-01 | 2012-06-28 | Impact Biomedicines, Inc. | Bi-aryl meta-pyrimidine inhibitors of kinases |
EP2032543A1 (en) | 2006-06-15 | 2009-03-11 | Boehringer Ingelheim International GmbH | 2-anilino-4-aminoalkyleneaminopyrimidines |
EP2043651A2 (en) * | 2006-07-05 | 2009-04-08 | Exelixis, Inc. | Methods of using igf1r and abl kinase modulators |
CA2693594A1 (en) * | 2007-07-17 | 2009-01-22 | Rigel Pharmaceuticals, Inc. | Cyclic amine substituted pyrimidinediamines as pkc inhibitors |
-
2009
- 2009-02-20 JP JP2010547802A patent/JP5586482B2/ja active Active
- 2009-02-20 SI SI200931588A patent/SI2252300T1/sl unknown
- 2009-02-20 DK DK09711944.0T patent/DK2252300T3/en active
- 2009-02-20 LT LTEP09711944.0T patent/LT2252300T/lt unknown
- 2009-02-20 BR BRPI0907724A patent/BRPI0907724B8/pt active IP Right Grant
- 2009-02-20 HU HUE09711944A patent/HUE030307T2/en unknown
- 2009-02-20 EP EP09711944.0A patent/EP2252300B1/en active Active
- 2009-02-20 PT PT97119440T patent/PT2252300T/pt unknown
- 2009-02-20 US US12/867,928 patent/US8530466B2/en active Active
- 2009-02-20 RU RU2010138899/14A patent/RU2490015C2/ru active
- 2009-02-20 CA CA2715962A patent/CA2715962C/en active Active
- 2009-02-20 PL PL09711944T patent/PL2252300T3/pl unknown
- 2009-02-20 MX MX2010009159A patent/MX2010009159A/es active IP Right Grant
- 2009-02-20 AU AU2009215430A patent/AU2009215430B2/en active Active
- 2009-02-20 WO PCT/US2009/034718 patent/WO2009105675A1/en active Application Filing
- 2009-02-20 CN CN2009801139108A patent/CN102014917A/zh active Pending
- 2009-02-20 KR KR1020107021085A patent/KR101614555B1/ko active IP Right Grant
- 2009-02-20 ES ES09711944.0T patent/ES2610880T3/es active Active
-
2011
- 2011-05-12 HK HK11104696.6A patent/HK1150555A1/zh unknown
-
2017
- 2017-01-12 HR HRP20170050TT patent/HRP20170050T1/hr unknown
- 2017-01-18 CY CY20171100070T patent/CY1118655T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
US20110046126A1 (en) | 2011-02-24 |
LT2252300T (lt) | 2017-02-10 |
CA2715962A1 (en) | 2009-08-27 |
ES2610880T3 (es) | 2017-05-03 |
CY1118655T1 (el) | 2017-07-12 |
JP5586482B2 (ja) | 2014-09-10 |
MX2010009159A (es) | 2010-09-14 |
HUE030307T2 (en) | 2017-04-28 |
US8530466B2 (en) | 2013-09-10 |
AU2009215430B2 (en) | 2015-02-12 |
PT2252300T (pt) | 2017-01-06 |
AU2009215430A1 (en) | 2009-08-27 |
EP2252300A1 (en) | 2010-11-24 |
JP2011513230A (ja) | 2011-04-28 |
HK1150555A1 (zh) | 2012-01-06 |
BRPI0907724B8 (pt) | 2021-05-25 |
BRPI0907724B1 (pt) | 2019-12-17 |
RU2490015C2 (ru) | 2013-08-20 |
KR101614555B1 (ko) | 2016-04-21 |
WO2009105675A1 (en) | 2009-08-27 |
KR20100126422A (ko) | 2010-12-01 |
PL2252300T3 (pl) | 2017-04-28 |
CA2715962C (en) | 2017-03-07 |
CN102014917A (zh) | 2011-04-13 |
DK2252300T3 (en) | 2017-02-06 |
HRP20170050T1 (hr) | 2017-03-10 |
RU2010138899A (ru) | 2012-03-27 |
BRPI0907724A2 (pt) | 2017-06-13 |
EP2252300B1 (en) | 2016-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1150555A1 (zh) | 用於治療動脈硬化的 -嘧啶二元胺的應用 | |
HRP20130357T1 (en) | Novel compounds useful for the treatment of degenerative and inflammatory diseases. | |
ZA200902374B (en) | Compositions useful for the treatment of diabetes | |
EP2101785A4 (en) | TREATMENT OF IT SEC | |
EP2361089A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE | |
IL200796A0 (en) | Device for the treatment of laundry using biocides | |
ZA201001264B (en) | 1-amino-alkylcycohxane derivatives for the treatment of cochleat tinnitus | |
GB0711342D0 (en) | Well treatment | |
GB0800145D0 (en) | Skincare treatment | |
IL205137A0 (en) | 5-cyanothienopyridines for the treatment of tumours | |
IL210290A0 (en) | Use of pyrimidylaminobenzamide derivatives for the treatment of fibrosis | |
ZA201007362B (en) | Conjugates for the treatment of mesothelioma | |
GB0715790D0 (en) | Drug combination for the treatment of sialorrhoea | |
HK1145634A1 (en) | Treatment of atherosclerosis | |
EP2174956A4 (en) | COMPOSITIONS FOR ANTIFIBRINOLYSIS THERAPY | |
ZA201005306B (en) | 5-o-substituted 3-n-phenyl-1,3,4-oxadiazolones for medical use | |
GB0716784D0 (en) | Well treatment | |
IL207668A0 (en) | Beloxepin, its enantiomers, and analogs thereof for the treatment of pain | |
PL2252302T3 (pl) | Kompozycja do leczenia zapalenia kości i stawów | |
GB0602857D0 (en) | The treatment of sialorrhoea | |
EP2328577A4 (en) | TREATMENT OF LOSS OF HEARING | |
GB0703491D0 (en) | The treatment of hyperhidrosis | |
GB0703492D0 (en) | The treatment of hyperhidrosis | |
GB0809319D0 (en) | The treatment of puritus | |
GB0821381D0 (en) | Compositions for the treatment of dry eye |